9. latest developments reach - clepa.eu · phenolphthalein 201-004-7 77-09-8 matt griffin...

29
REACH Timo Unger Latest Developments Latest Developments Latest Developments Latest Developments

Upload: vukiet

Post on 28-Feb-2019

214 views

Category:

Documents


0 download

TRANSCRIPT

REACH

Timo Unger

Latest DevelopmentsLatest DevelopmentsLatest DevelopmentsLatest Developments

Hyundai Motor Europe Tech. CenterContent

• Interesting facts to know from ACEA / TF REACH

– Structure of ACEA WG on Materials & Substances (WG M/S)

– Status of the „Substance Pilot“ discussion

• A small motivation to survive

• Status of the most critical communication challenges

– „Lead Time Shortage“

– „Missing Unique Identifiers“

– „Repair as Produced“

• Status of our key SVHCs

2

Hyundai Motor Europe Tech. Center

ACEA WG M&SACEA WG M&SACEA WG M&SACEA WG M&S

Unger/HyundaiUnger/HyundaiUnger/HyundaiUnger/Hyundai

Kunze/ACEAKunze/ACEAKunze/ACEAKunze/ACEA

TF REACHTF REACHTF REACHTF REACH(Unger/Hyundai(Unger/Hyundai(Unger/Hyundai(Unger/HyundaiKunze/ACEA)Kunze/ACEA)Kunze/ACEA)Kunze/ACEA) Informal TF Health Informal TF Health Informal TF Health Informal TF Health & Safety& Safety& Safety& Safety(Cincetti/Fiat)(Cincetti/Fiat)(Cincetti/Fiat)(Cincetti/Fiat) Informal TF Informal TF Informal TF Informal TF BiocidesBiocidesBiocidesBiocides(Swindell/JLR)(Swindell/JLR)(Swindell/JLR)(Swindell/JLR) Informal TF Informal TF Informal TF Informal TF Process ChemicalsProcess ChemicalsProcess ChemicalsProcess Chemicals(Stein(Stein(Stein(Stein----Schaller/BMW)Schaller/BMW)Schaller/BMW)Schaller/BMW) Informal TF NanosInformal TF NanosInformal TF NanosInformal TF Nanos(Kunze / ACEA(Kunze / ACEA(Kunze / ACEA(Kunze / ACEAMeeuws/Toyota)Meeuws/Toyota)Meeuws/Toyota)Meeuws/Toyota) Informal TF VIAQInformal TF VIAQInformal TF VIAQInformal TF VIAQ(Nesa/Renault)(Nesa/Renault)(Nesa/Renault)(Nesa/Renault)Kunze/ACEA)Kunze/ACEA)Kunze/ACEA)Kunze/ACEA)

Structure of the ACEA WG M&S

Hyundai Motor Europe Tech. CenterSome of our current discussions...

• Beside the usual global nightmares (REACH, Nanos, BPR, CLP, GADSL/IMDS, VIAQ, EMF Directive, US ToSCA, ...) we also discuss several other (strategic, visionary) and intersting subjects, e.g.

– GAPSL (Process Chemicals)

– Global Substance Monitoring System

Hyundai Motor Europe Tech. CenterThe overall challenge for all of us...

• It is an unwritten duty for each company to keep track of all of these It is an unwritten duty for each company to keep track of all of these It is an unwritten duty for each company to keep track of all of these It is an unwritten duty for each company to keep track of all of these ongoingsongoingsongoingsongoings and to start actions if necessaryand to start actions if necessaryand to start actions if necessaryand to start actions if necessary

• Calculated effort Calculated effort Calculated effort Calculated effort (e.g. ADCA)(e.g. ADCA)(e.g. ADCA)(e.g. ADCA): approx. 45h (so far) x 80!?: approx. 45h (so far) x 80!?: approx. 45h (so far) x 80!?: approx. 45h (so far) x 80!?

– Due to limited internal capacities IMPOSSIBLE!IMPOSSIBLE!IMPOSSIBLE!IMPOSSIBLE! for each individual company!

EU REACH: SVHC Roadmap: EU REACH: SVHC Roadmap: EU REACH: SVHC Roadmap: EU REACH: SVHC Roadmap: RMORMORMORMO----assessment: for 440 substances until 2020 assessment: for 440 substances until 2020 assessment: for 440 substances until 2020 assessment: for 440 substances until 2020

= 50 RMOs/year = 50 RMOs/year = 50 RMOs/year = 50 RMOs/year

(80 substances by the end of 2014)(80 substances by the end of 2014)(80 substances by the end of 2014)(80 substances by the end of 2014)

Hyundai Motor Europe Tech. CenterThe Solution in EU

• In order to share the workload and increase efficiency, the TF REACH & ACEA WG M&S have agreed to establish the new “Substance Pilot” function

• Task Description:– Be main point of contact for the substance / group of substances

– Establish a network with the relevant manufacturers, associations, industry consortia

– Collect and consolidate latest information on the substance/(alternatives) for every relevant automotive application

– Report back at the TF REACH meetings, if necessary

Where mandated by the relevant associations:Where mandated by the relevant associations:Where mandated by the relevant associations:Where mandated by the relevant associations:

– Coordinate Automotive Industry activities, if needed

– Organize ad-hoc teleconferences and/or email exchange of the sub-group, if necessary

– Prepare proposals for decisions to be taken by the relevant associations

Total number ofTotal number ofTotal number ofTotal number of

substances under substances under substances under substances under

observationobservationobservationobservation

Substances with Substances with Substances with Substances with

substance pilotssubstance pilotssubstance pilotssubstance pilots

314314314314 140!140!140!140!

Hyundai Motor Europe Tech. CenterThe Solution in EU

3,8,10-Trioxa-9-stannatetradeca-5,12-dien-14-oic acid,

9,9-dibutyl-2-methyl-4,7,11-trioxo-, 1-methylethyl

ester, (Z,Z)-

22535-42-8 Martin Drozd [email protected]

3,8,10-Trioxa-9-stannatetradeca-5,12-dien-14-oic acid,

9,9-dibutyl-4,7,11-trioxo-, ethyl ester, (Z,Z)-13173-04-1 Martin Drozd [email protected]

5,7,12-Trioxa-6-stannatetracosa-2,9-dienoic acid, 6,6-

dibutyl-4,8,11-trioxo-, dodecyl ester, (Z,Z)-33466-31-8 Martin Drozd [email protected]

Acetate, S,S'-bisoctylmercapto-, dibutyltin 32011-18-0 Martin Drozd [email protected]

Bis (acetato) dibutyltin 17523-06-7 Martin Drozd [email protected]

Dibutyl tin1002-53-5

Martin Drozd [email protected]

Dibutyltinbis(2-ethylhexyl mercaptoacetate)10584-98-2

Martin Drozd [email protected]

Dibutylbis(octyl maleate)tin 17036-31-6 Martin Drozd [email protected]

Diisooctyl 4,4'-((dibutylstannylene)bis(oxy))bis(4-

oxoisocrotonate)

25168-21-2Martin Drozd [email protected]

Dibutylbis((1-oxoneodecyl)oxy)stannane 25168-22-3 Martin Drozd [email protected]

Dibutylbis(myristoyloxy)stannane28660-67-5

Martin Drozd [email protected]

Dibutylthioxostannane 4253-22-9 Martin Drozd [email protected]

Dibutylbis[(1-oxoisooctadecyl)oxy]stannane 59963-28-9 Martin Drozd [email protected]

Silicic acid (H4SiO4), tetraethyl ester, reaction

products with bis(acetyloxy)dibutylstannane

93925-42-9Martin Drozd [email protected]

Dibutylbis(ethyl 3-oxobutyrato-O1',O3)tin 54581-65-6 Martin Drozd [email protected]

Dibutyltin bis(2-ethylhexyl-3-mercaptopropionate) 53202-61-2 Martin Drozd [email protected]

Dibutyltin bis(benzyl maleate) 7324-74-5 Martin Drozd [email protected]

Dibutyltin bis(cyclohexyl maleate) 5587-52-0 Martin Drozd [email protected]

Dibutyltin bis(isooctyl mercaptoacetate) 25168-24-5 Martin Drozd [email protected]

Dibutyltin bis(lauryl β-mercaptopropionate) 51287-83-3 Martin Drozd [email protected]

Dibutyltin bis(octylthioglycolate) 2781-09-1 Martin Drozd [email protected]

Dibutyltin bis(oleyl maleate) 29881-72-9 Martin Drozd [email protected]

Dibutyltin di(isooctyl 3-mercaptopropionate) 26761-46-6 Martin Drozd [email protected]

Dibutyltin diacetate1067-33-0

Martin Drozd [email protected]

Dibutyltin dibenzoate 5847-54-1 Martin Drozd [email protected]

Dibutyltin dibutoxide 3349-36-8 Martin Drozd [email protected]

Dibutyltin dihexanoate 19704-60-0 Martin Drozd [email protected]

Dibutyltin dilaurate77-58-7

Martin Drozd [email protected]

Dibutyltin dilauryl mercaptide 1185-81-5 Martin Drozd [email protected]

Dibutyltin dimaleate 10192-92-4 Martin Drozd [email protected]

Dibutyldimethoxystannane 1067-55-6 Martin Drozd [email protected]

Dibutyltin dioctanoate 4731-77-5 Martin Drozd [email protected]

Dibutyltin dioleate13323-62-1

Martin Drozd [email protected]

Dibutyltin dipalmitate13323-63-2

Martin Drozd [email protected]

Dibutyltin disalicylate 14214-24-5 Martin Drozd [email protected]

Dibutyltin distearate 5847-55-2 Martin Drozd [email protected]

Dibutyltin hydrogen borate75113-37-0

Martin Drozd [email protected]

Dibutyltin isooctanoate 85702-74-5 Martin Drozd [email protected]

Dibutyltin linoleate 85391-79-3 Martin Drozd [email protected]

Dibutyltin linolenate 95873-60-2 Martin Drozd [email protected]

Dibutyltin maleate78-04-6

Martin Drozd [email protected]

Dibutyltin mercaptoacetate 78-20-6 Martin Drozd [email protected]

Dibutyltin mercaptopropionate78-06-8

Martin Drozd [email protected]

Dibutyltin oxide Martin Drozd [email protected]

Dibutyltin S,S'-bis(isooctyl mercaptoacetate)

Acetic acid, 2,2'-[(dimethylstannylene)bis(thio)]bis-,

1,1'-diisooctyl ester)

Martin Drozd [email protected]

Dibutytin di(2-ethylhexyl maleate) 15546-12-0 Martin Drozd [email protected]

Di-n-butyltin bis(methyl maleate) 15546-11-9 Martin Drozd [email protected]

Di-n-butyltin di(monobutyl)maleate15546-16-4

Martin Drozd [email protected]

Di-n-butyltin di-2-ethylhexanoate 2781-10-4 Martin Drozd [email protected]

Tin, dibutyl(1,2-ethanediamine-N,N')bis(monoisooctyl

2-butenedioato-O')-

163206-28-8Martin Drozd [email protected]

Tin, dibutyl[N-(carboxymethyl)-N-(2-

hydroxyethyl)glycinato(2-)]-

68239-46-3Martin Drozd [email protected]

Tin, dibutylbis(2,4-pentanedionato-O,O')-, (OC-6-11)-22673-19-4

Martin Drozd [email protected]

Tin, dibutylbis(methyl 3-mercaptopropanoato-O,S)- 32011-19-1 Martin Drozd [email protected]

Tin, dibutylbis(N,N-diethylethanamine)difluoro- 67924-24-7 Martin Drozd [email protected]

Lead di(acetate) 206-104-4 301-04-2 Frank Schlüter [email protected]

4,4'-isopropylidenediphenol (bisphenol A) 201-245-8 80-05-7 Elena Genero [email protected]

Bis(2-ethylhexyl)-3,4,5,6-tetrabromophthalate (TBPH) 247-426-5 26040-51-7 Matt Griffin [email protected]

Dihexyl phthalate 201-559-5 84-75-3 Matt Griffin [email protected]

Ethane-1, 2-Bis (pentabromophenyl) ("EBP") 284-366-9 84852-53-9 Matt Griffin [email protected]

Nickel Group Anne-Sophie Henault [email protected]

818-08-6

1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl

esters, C7-rich (DIHP)276-158-1 71888-89-6 Matt Griffin [email protected]

Trilead diarsenate 222-979-5 3687-31-8 Frank Schlüter [email protected]

Bis(2-methoxyethyl) phthalate 204-212-6 117-82-8 Matt Griffin [email protected]

1,2-bis(2-methoxyethoxy)ethane; TEGDME;

triethylene glycol dimethyl ether; triglyme203-977-3 112-49-2 Jonathan Swindell [email protected]

N,N-dimethylacetamide (DMAC) 204-826-4 127-19-5 Duarri [email protected]

Lead diazide; Lead azide 236-542-1 13424-46-9 Frank Schlüter [email protected]

Lead styphnate 239-290-0 15245-44-0 Frank Schlüter [email protected]

Phenolphthalein 201-004-7 77-09-8 Matt Griffin [email protected]

Lead dipicrate 229-335-2 6477-64-1 Frank Schlüter [email protected]

Formaldehyde, oligomeric reaction products with

aniline (technical MDA)500-036-1 25214-70-4 Michel/Glabbeek l.v.glabbeek@mitsubishi-motors-

euro.com

2-Methoxyaniline; o-Anisidine 201-963-1 90-04-0 Frank Schlüter [email protected]

Lead oxide 215-267-0 1317-36-8 Frank Schlüter [email protected]

Lead tetroxide 215-235-6 1314-41-6 Frank Schlüter [email protected]

Lead (II) carbonate 209-943-4 598-63-0 Frank Schlüter [email protected]

Diboron trioxide, boric oxide 215-125-8 1303-86-2 Elena Genero [email protected]

Lead(II) bis(methanesulfonate) 401-750-5 17570-76-2 Frank Schlüter [email protected]

Di-n-pentyl phthalate 205-017-9 131-18-0 Matt Griffin [email protected]

N-pentyl-isopentylphtalate not specified not specified Matt Griffin [email protected]

Hexahydro-4-methylphthalic anhydride 243-072-0 19438-60-9 Matt Griffin [email protected]

Hexahydromethylphthalic anhydride 247-094-1 25550-51-0 Jonathan Swindell [email protected]

Hexahydro-1-methylphathalic anhydride 256-356-4 48122-14-1 Jonathan Swindell [email protected]

Hexahydro-3-methylphathalic anhydride 260-566-1 57110-29-9 Jonathan Swindell [email protected]

Decabromodiphenyl ether (Deca BDE) 214-604-9 1163-19-5 Matt Griffin [email protected]

Tetrabromobisphenol A (TBBPA) 201-236-9 79-94-7 Elena Genero [email protected]

Diazene-1,2-dicarboxamide (C,C'-azodi(formamide))

(ADCA)204-650-8 123-77-3 Kobayashi-san

[email protected]

o.jp

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated not specified not specified Michel/Glabbeekl.v.glabbeek@mitsubishi-motors-

euro.com

Phenol, 4-nonyl-, branched and linear covering all

individual isomers with an alkyl chain of carbon

number 9 and UVCB substances which include linear

and branched alkyl chains with a carbon number of 9

not specified not specified Michel/Glabbeekl.v.glabbeek@mitsubishi-motors-

euro.com

Pentalead tetraoxide sulphate 235-067-7 12065-90-6 Frank Schlüter [email protected]

Dioxobis(stearato)trilead 235-702-8 12578-12-0 Frank Schlüter [email protected]

Lead dinitrate 233-245-9 10099-74-8 Frank Schlüter [email protected]

Tetralead trioxide sulphate 235-380-9 12202-17-4 Frank Schlüter [email protected]

Lead titanium trioxide 235-038-9 12060-00-3 Frank Schlüter [email protected]

Acetic acid, lead salt, basic 257-175-3 51404-69-4 Frank Schlüter [email protected]

Pyrochlore, antimony lead yellow 232-382-1 8012-00-8 Frank Schlüter [email protected]

Tetraethyllead 201-075-4 78-00-2 Frank Schlüter [email protected]

Dibasic lead phthalate (phthalate(2-dioxotrilead)) 273-688-5 69011-06-9 Matt Griffin [email protected]

Lead cynamidate 244-073-9 20837-86-9 Frank Schlüter [email protected]

Silicic acid, barium salt, lead-doped 272-271-5 68784-75-8 Frank Schlüter [email protected]

Lead Titanium Zirconium Oxide 235-727-4 12626-81-2 Frank Schlüter [email protected]

Basic lead carbonate (trilead

bis(carbonate)dihydroxide)215-290-6 1319-46-6 Frank Schlüter [email protected]

Fatty acids, C16-18, lead salts 292-966-7 91031-62-8 Frank Schlüter [email protected]

Sulfurous acid, lead salt, dibasic 263-467-1 62229-08-7 Frank Schlüter [email protected]

Basic lead sulphate (lead oxide sulphate) 234-853-7 12036-76-9 Frank Schlüter [email protected]

Lead bis(tetrafluoroborate) 237-486-0 13814-96-5 Frank Schlüter [email protected]

Silicic acid, lead salt 234-363-3 11120-22-2 Frank Schlüter [email protected]

N,N-dimethylformamide; dimethyl formamide (DMF) 200-679-5 68-12-2 Duarri [email protected]

Hyundai Motor Europe Tech. CenterThe Solution in EU

Benzyl butyl phthalate (BBP) 201-622-7 85-68-7 Matt [email protected]

om

Cobalt dichloride 231-589-4 7646-79-9 Ortwin MeeuwsOrtwin.Meeuws@toyota-

europe.com

Sodium dichromate 234-190-3 7789-12-0 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Sodium dichromate 10588-01-9 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Bis (2-ethylhexyl)phthalate (DEHP) 204-211-0 117-81-7 Matt [email protected]

om

Dibutyl phthalate (DBP) 201-557-4 84-74-2 Matt [email protected]

om

Lead hydrogen arsenate 232-064-2 7784-40-9 Frank Schlüter [email protected]

Hexabromocyclododecane (HBCDD) and all

major diastereoisomers identified

247-148-4

221-695-9 25637-99-4 Matt Griffin

[email protected]

om

Hexabromocyclododecane (HBCDD) and all

major diastereoisomers identified3194-55-6 Matt Griffin

[email protected]

om

alpha-Hexabromocyclododecane (HBCDD) 134237-50-6 Matt [email protected]

om

beta-Hexabromocyclododecane (HBCDD) 134237-51-7 Matt [email protected]

om

gamma-Hexabromocyclododecane (HBCDD) 134237-52-8 Matt [email protected]

om

Aluminosilicate Refractory Ceramic Fibres 604-314-4 142844-00-6 Hans-Ulrich Bahl [email protected]

Zirconia Aluminosilicate Refractory Ceramic

Fibres604-314-4 142844-00-6 Hans-Ulrich Bahl [email protected]

Diisobutyl phthalate / Dibutyl phthalate (DIBP) 201-553-2 84-69-5 Matt [email protected]

om

Lead chromate 231-846-0 7758-97-6 Frank Schlüter [email protected]

Lead chromate molybdate sulphate red (C.I.

Pigment Red 104)235-759-9 12656-85-8 Frank Schlüter [email protected]

Lead sulfochromate yellow (C.I. Pigment Yellow

34)215-693-7 1344-37-2 Frank Schlüter [email protected]

Boric acid234-343-4

11113-50-1 Elena Genero [email protected]

Boric acid 233-139-2 10043-35-3 Elena Genero [email protected]

Potassium dichromate 231-906-6 7778-50-9 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Ammonium dichromate 232-143-1 7789-09-5 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Potassium chromate 232-140-5 7789-00-6 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Sodium chromate 231-889-5 7775-11-3 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Lead and its compounds 231-100-4 7439-92-1 Frank Schlüter [email protected]

Cobalt(II) sulphate 233-334-2 10124-43-3 Ortwin MeeuwsOrtwin.Meeuws@toyota-

europe.com

Cobalt(II) dinitrate 233-402-1 10141-05-6 Ortwin MeeuwsOrtwin.Meeuws@toyota-

europe.com

Cobalt(II) carbonate 208-169-4 513-79-1 Ortwin MeeuwsOrtwin.Meeuws@toyota-

europe.com

Cobalt(II) diacetate 200-755-8 71-48-7 Ortwin MeeuwsOrtwin.Meeuws@toyota-

europe.com

Chromium trioxide 215-607-8 1333-82-0 Wolfgang MarquardtWolfgang.WM.Marquardt@b

mw.de

Chromic acid, Oligomers of chromic acid and

dichromic acid, Dichromic acid231-801-5 7738-94-5 Wolfgang Marquardt

Wolfgang.WM.Marquardt@b

mw.de

Chromic acid, Oligomers of chromic acid and

dichromic acid, Dichromic acid236-881-5 13530-68-2 Wolfgang Marquardt

Wolfgang.WM.Marquardt@b

mw.de

Substance Pilots

Hyundai Motor Europe Tech. Center

Becaue not only Becaue not only Becaue not only Becaue not only

the textile industry is an easy the textile industry is an easy the textile industry is an easy the textile industry is an easy

target....target....target....target....

Why do you have to listen to me?

Hyundai Motor Europe Tech. CenterLead Time Shortage

10

Hyundai Motor Europe Tech. CenterLead time shortage

But only if the substance is identified already ONE year before*

360 days + 180 days = 540 days (worste case)

=> Time needed for newly identified substances!

� Experience out of 13 years of data collection throughout complex supply chains:– Under normal conditions a reliable investigation via IMDS can be performed within 2-6 month= up to 180 days!

* Time needed- to adjust existing tools and processes (GADSL is updated max 2/year!)

- for suppliers to check and update their material reportings

11

Hyundai Motor Europe Tech. CenterLead time shortage – Examples

Substance Publication on the ROI

Publication of the Annex XV

Dossier(Start of Public Consultation (45 days)) Delta [days](A-B) Publication of

the CL

Delta [days](A-C)

DecaBDEBis(pentabromo-phenyl) ether 06.08.2012 03.09.2012 28 19.12.2012 142

NMP 1-methyl-2-pyrrolidone 21.02.2011 21.02.2011 0 20.06.2011 119

DBPDibutyl phthalate 27.06.2008 30.06.2008 3 28.10.2008 123

Dichromium tris (chromate) 20.04.2011 01.08.2011 103 19.12.2011 243

Example:

Substance

APublication on the ROI

BPublication of the Annex XV

Dossier(Start of Public Consultation (45 days)) Delta [days](A-B) C

Publication of the CL

Delta [days](A-C)

First indication on which substance(s) possibly to

come next Recommended start of

data evaluation

Necessity to know if you are affected by the substance(s)

(Voluntary; Only if I want to give input into the the

stakeholder consultation)Recommended end of the

data evaluation and interpretation

Time, available for the

voluntary data evaluation

Necessity to know if you are affected by the

substance(s) (Mandatory to fulfill my

legal obligations)Definite end of the data evaluation and

interpretation

Time, available for the mandatorydata evaluation

Not sufficient lead time to provide reliable and appropriate informationEspecially for industry with very complex product structure = supply chains

12

Hyundai Motor Europe Tech. CenterLead time shortage – Consequences and Solutions

Automotive Industry Proposal:

� We support EC actions to have more interactions between Member States/Commission and Industry to share the pre-intentions

Substance identity should be know at least 1,5 years before the start

of the public consultationAlready in that early stage, MS should consider Industry opinions in the definition of the appropriate RMOIt would be beneficial for all parties if Member States would publish a list of substances already under scrutiny on a central platform (e.g. ECHA page)

Consequence:

� Questionable quality of stakeholder input during consultation

Early industry involvement by Member States is crucial(Benchmark: Nickel discussion in France!)

This has to be long before the ROI inclusion

13

Hyundai Motor Europe Tech. CenterCurrent status of discussion

• Not only Automotibve Industry was requesting more lead time and more transparency

• REACH SVHC 2020 Roadmap was already taking up the discussion:

Aims of the roadmap:

– Presenting a credible process to ensure the 2020 SVHC objective is met.

– Defining a process or methodology, with clear deliverables, planning and share of responsibilities to increase predictability, Simplify the process, increase efficiency/effectiveness, streamline

• Related conclusion of the roadmap:

– Setting up a platform on ECHA website for the communication activities

-> We will know (and can start to work) earlier on the substances to come next

-> Not mandatory for MS

– No clear statement to involve industry in the very early stage of the RMOA

BUT:

– Member States (e.g. Germany, France) have already states to always involve industry asap

14

Hyundai Motor Europe Tech. CenterCurrent status of discussion

Process acc. to

SVHC Roadmap:

Example how it could

work (Germany):

15

Source: Dr. Frauke Schröder, BAuA

More information under:

http://www.reach-clp-biozid-helpdesk.de/de/Veranstaltungen/2014/Veranstaltungen14-0327.html

Hyundai Motor Europe Tech. CenterMissing Unique Identifiers

16

Hyundai Motor Europe Tech. CenterAnother reporting Challenge: Missing substance identifiers

� There is an increasing number of SVHCs without any unique identifier (CAS/EC number) falling under authorisation:� Aluminosilicate Refractory Ceramic Fibres� Zirconia Aluminosilicate Refractory Ceramic Fibres� 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated� Nonylphenol ethoxylates� Phenol, 4-nonyl-, branched and linear covering all individual isomers …

� Industry is not able to perform a proper investigation on the usage of these SVHCs (especially not within the given timeframe).

Suggested for Annex XIV inclusion

� Automotive Industry Proposal to ECHA & EC:Help industry to easily find the corresponding substance identifiers (CAS / EC number) in all relevant documentations

17

Hyundai Motor Europe Tech. CenterECHA Opinion

� ECHA is aware but saying, that…:� ...these entries are representing group entries with more then just one

identifier.� …numerical identifiers are not mandatory for substance identification

and will only be provided if they are available or appropriate.� …sufficient information has been provided to enable users of substances

to determine whether they fall within the definition of that group.� ...they acknowledge that this requires a sufficient knowledge of

the chemistry and the naming of a substance which is not necessarily available in all SMEs.

� the given information is fully in line with the scope and aim of REACH.� it is justified not to include EC and CAS numbers for certain

entries on the CL and Annex XIV.

18

Hyundai Motor Europe Tech. CenterConsequences from ECHA answer

� End users have to rely on the reporting from their supply chain� Very often, SME-suppliers (but not exclusively!) don´t have chemical expertise and thus are not able to perform a proper investigation on the usage of these unidentified SVHCs (especially not within the given timeframe).

� Reporting quality consequently is poor (our experience)� Negative consequences for several REACH duties:

� Communication (Art 33), Notification (Art 7.2), all input into stakeholder consultations

Conclusion: The given information is NOT fully in line with the scope and aim of REACH!

19

Hyundai Motor Europe Tech. CenterAutomotive Industry Approach

� Following the ECHA answer, Automotive Industry has defined the corresponding substances (urgently needed!)

� Results will be communicated to the complete supply chain via IMDS & GADSL

� Suppliers will have to report acc. to our defined identifiers

But:� What happens if each industryis doing this individually and if the results are different?

� What is the negative consequence for the chemical industry because of unjustified black listing?

Discussions have started in the REACH

Cross Sector Group (RCSG) to agree on a common approach

20

Name CAS-Nr.

9016-45-9

27942-26-3

26027-38-3

7311-27-5

20427-84-3

34166-38-6

27942-27-4

14409-72-4

104-35-8

156609-10-8

127087-87-0

37205-87-1

84852-15-3

26543-97-5

104-40-5

17404-66-9

30784-30-6

52427-13-1

186825-36-5

142731-63-3

9081-99-6

2315-67-5

2315-61-9

9002-93-1

2497-59-8

RCF 142844-00-6

4-Nonylphenol, branched and linear, ethoxylated

4-Nonylphenol, branched and linear

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated

Hyundai Motor Europe Tech. CenterCurrent status of discussion

• Within the framework of the HelpNet, ECHA proposed new Q&A for the REACH FAQ update 7.0.

• A new Q&A will be added regarding SVHC - specific identifier issue.

21

Draft FAQ 12342

Certain entries in the Candidate List of substances of very high concern (SVHC) do not refer to a specific identifier (e.g. EC or CAS number), but, instead, to a family of substances (e.g. "4-Nonylphenol, branched and linear, ethoxylated"). In such cases, the corresponding supporting documentation on ECHA’s website needs to be consulted, as it provides helpful examples of substances covered by the entry in question.

However, what can be concluded regarding the SVHC status of substances which are covered by the same family but are not included in the list of examples in the supporting documentation?

The list of substances provided in the supporting documentation of generic Candidate List entries is indicative and not exhaustive, unless otherwise specified. Since such entries are not limited to the substances explicitly mentioned in the supporting documentation, any substance which is covered by the same generic description should be considered as an SVHC, unless the company can demonstrate that the substance should rather be considered as different from the entry and, thus, not an SVHC. In the latter case, a scientifically valid justification should be made available to enforcement authorities, including a position paper supported by spectroscopic and analytical data, in particular with regard to the properties which have led to the inclusion of the substance in the Candidate List.

How can a non chemical company fulfill this expectation?

Hyundai Motor Europe Tech. CenterRepair as produced

22

Hyundai Motor Europe Tech. CenterSubstance Substitution vs. Spare Parts Production

• Spare parts (still produced in very low volumes & often by SMEs) have to be re-developed & re-validated (several times?)– Not possible

• Experience from ELV: Will have negative consequences on service parts strategy– Results in:

• Increasing costs for customers or• Decrease of the vehicle lifetime

• Alternative solution: Spare parts are produced outside of Europe

Lifecycle of a car Lifecycle of a car Lifecycle of a car Lifecycle of a car –––– From the cradle to the graveFrom the cradle to the graveFrom the cradle to the graveFrom the cradle to the grave

Sunset DateSunset DateSunset DateSunset Date= Substance = Substance = Substance = Substance SubstitutionSubstitutionSubstitutionSubstitutionPublicationPublicationPublicationPublicationAnnex XIVAnnex XIVAnnex XIVAnnex XIVMaterial Material Material Material DevelopmentDevelopmentDevelopmentDevelopment Component Component Component Component ProductionProductionProductionProductionMaterial Material Material Material ProductionProductionProductionProduction Vehicle Vehicle Vehicle Vehicle ProductionProductionProductionProduction Vehicle Vehicle Vehicle Vehicle ProductionProductionProductionProductionComponent Component Component Component DevelopmentDevelopmentDevelopmentDevelopment Vehicle Vehicle Vehicle Vehicle DevelopmentDevelopmentDevelopmentDevelopment Vehicle Vehicle Vehicle Vehicle LifetimeLifetimeLifetimeLifetime Vehicle Vehicle Vehicle Vehicle RecyclingRecyclingRecyclingRecycling

OEM or SME

Spare Parts Spare Parts Spare Parts Spare Parts ProductionProductionProductionProduction8 8 8 8 ---- 20 years 20 years 20 years 20 years (after EOP)(after EOP)(after EOP)(after EOP) Spare Parts availSpare Parts availSpare Parts availSpare Parts availabilityabilityabilityability0 0 0 0 ---- X years X years X years X years ((((after EOSP)after EOSP)after EOSP)after EOSP)SMESMESMESMESpare Parts Spare Parts Spare Parts Spare Parts ProductionProductionProductionProduction3 3 3 3 ---- 7 years7 years7 years7 yearsOEM

EOP: End of Production

EOSP: End of Spareparts Production

Hyundai Motor Europe Tech. CenterSpare parts under Authorisation – Possible Solution

• Add to REACH Annex XIV a clause Add to REACH Annex XIV a clause Add to REACH Annex XIV a clause Add to REACH Annex XIV a clause similar to ELV, e.g. similar to ELV, e.g. similar to ELV, e.g. similar to ELV, e.g.

“Substances for spare parts that are manufactured after the sunset date, which are used for vehicles that ceased production before the sunset date shall be exempted from the provisions of Article 56, REACH”

Status: 25 March 2014

Hyundai Motor Europe Tech. CenterCurrent status of discussion

• Since then, the debates have gained speed on several levels and in different institutions

– EU Commission: DG ENTR & DG ENV

– EU Parliament

– Member States: CARACAL, Member Stats Committee, National Ministries of Environmet & Economy

– Trade Associations: Supporting papers or own position papers (e.g. Aerospace and defense (ASD), European Airlines (AEA), SMEs (UEAPME), ...

• Already common understanding that a solution needs to be provided to industry

• EC + MS have already started to work on the subject with different suggestions for spare parts (and other low volume products?):

– Prolong the sunset dates

– Implement an authorisation light

– Prolong the authorisation (up to 20 years)

– Follow the example from the ELV Annex II

– ...

• EC will invite to a workshop by the end of June

25

Hyundai Motor Europe Tech. CenterHBCD update

• REACH

> Last Application Date 21/02/2014

> 2 applications for authorisation submitted (0013-1 & 0013-2)

> Only applicable for buildings industry

> No authorisation for automotive uses has been applied for

• Japan

– Cabinet decision published http://www.meti.go.jp/english/press/2014/0314_03.html

– Prohibition could apply to imported materials (for repair)

– Exemption can be revisited if HBCD usage does not decline.

• Canada

– Gazette publication expected Summer 2014, expecting to affect auto’s, with extended phase-out for spare parts

Hyundai Motor Europe Tech. CenterPhthalates

• DBP, BBP, DIBP

– No automotive use applied for.

– One ECHA opinion published for DBP (in closed system manufacture of maleic anhydride)

• Recommended review period of 12 years

• DEHP

– Authorisation

• Applicants meeting with Rapporteurs and ECHA

– Short (3 hours) – not enough time to respond to questions

– Socio-economic arguments will determine whether uses will be authorised

– RAC / SEAC meeting since the trialogue – confidential – no feedback

– MSCA’s – not all appear to have read / understand information submitted

– Request for ACEA support

» ACEA to write to MSCA attaching our input to Public Consultation

• ECHA opinion for Rolls Royce DEHP aerospace use published

– Recommended review period of 7 years

Substance of greatest concern - DEHP

According to sector wide investigations, DEHP has been found in a very high number of parts / spare parts

� Typical materials– Rubber, Nitrile Butadiene Rubber (NBR), PVC, Elastomers, Adhesives, Sealants etc.

� Typical applications– Wiring harnesses, Hoses, Label, Lining and trim strips, Plastic parts

Note: No AfA e.g. for DEHP in RubberIf you have DEHP in rubber, get rid of it!!!

Hyundai Motor Europe Tech. Center

29

CooperationCooperationCooperationCooperation

The key to a successful material The key to a successful material The key to a successful material The key to a successful material

reporting is the close cooperation reporting is the close cooperation reporting is the close cooperation reporting is the close cooperation

between OEM s and suppliersbetween OEM s and suppliersbetween OEM s and suppliersbetween OEM s and suppliers